Mediolanum International Funds’s Edwards Lifesciences EW Stock Holding History

Mediolanum International Funds’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.7M	Buy	281,870 +248,296	+740%	+$20.8M	0.22%	105
2026 Q1	$2.67M	Buy	33,574 +24,920	+288%	+$2.05M	0.03%	327
2025 Q4	$746K	Sell	8,654 -3,062	-26%	-$251K	0.01%	388
2025 Q3	$904K	Buy	11,716 +167	+1%	+$13K	0.01%	387
2025 Q2	$903K	Sell	11,549 -36,677	-76%	-$2.74M	0.01%	374
2025 Q1	$3.42M	Sell	48,226 -6,114	-11%	-$438K	0.05%	287
2024 Q4	$4.02M	Buy	54,340 +354	+0.7%	+$24.8K	0.05%	265
2024 Q3	$3.59M	Sell	53,986 -67,871	-56%	-$4.93M	0.05%	284
2024 Q2	$10.6M	Sell	121,857 -5,973	-5%	-$529K	0.17%	117
2024 Q1	$12.2M	Buy	+127,830	New	+$10.7M	0.2%	115

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Mediolanum International Funds's EW Position: Q2 2026 in Review

Mediolanum International Funds increased its Edwards Lifesciences (EW) stake by 740% in Q2 2026, buying an estimated $20.8M and bringing the position to 281,870 shares worth $25.7M. The position accounts for 0.22% of the portfolio, ranked #105.

Mediolanum International Funds first reported a position in EW in Q1 2024 and has held it in 10 quarters since. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Mediolanum International Funds held 281,870 shares of Edwards Lifesciences worth $25.7M as of Q2 2026.
Mediolanum International Funds bought 248,296 Edwards Lifesciences shares in Q2 2026, an estimated $20.8M.
Edwards Lifesciences made up 0.22% of Mediolanum International Funds's portfolio in Q2 2026, its #105 holding.
Mediolanum International Funds first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.